First Nebraska Trust Co Invests $436,000 in CME Group Inc. $CME

First Nebraska Trust Co purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,974 shares of the financial services provider’s stock, valued at approximately $436,000.

Other large investors also recently made changes to their positions in the company. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group lifted its position in CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after buying an additional 37 shares in the last quarter. Endowment Wealth Management Inc. boosted its position in CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the last quarter. NBT Bank N A NY increased its holdings in CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after buying an additional 38 shares during the last quarter. Finally, Resonant Capital Advisors LLC increased its stake in shares of CME Group by 3.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 39 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity at CME Group

In other news, Director William R. Shepard acquired 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

NASDAQ CME opened at $274.98 on Friday. The company has a market cap of $98.88 billion, a PE ratio of 23.32, a price-to-earnings-growth ratio of 3.20 and a beta of 0.23. The firm’s 50-day simple moving average is $251.17 and its two-hundred day simple moving average is $279.65. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the previous year, the company earned $2.96 earnings per share. CME Group’s revenue for the quarter was up .8% on a year-over-year basis. Research analysts predict that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is currently 44.11%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CME. Morgan Stanley increased their price objective on shares of CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research report on Thursday, July 23rd. Barclays reduced their target price on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. The Goldman Sachs Group decreased their target price on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. Finally, Bank of America upped their price target on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.